Stoke Therapeutics, Inc. (STOK)

SEC filing

Stoke Therapeutics, Inc.

STOK · CIK 1623526

4 · Dec 5, 2025 · Allan Jonathan sold 9,803 shares at $31.25/share ($306.3K); exercised options for 6,000 shares

Allan Jonathan sold 9,803 shares at $31.25/share ($306.3K); exercised options for 6,000 shares

xslF345X05/form4-12062025_011219.xml

xslF345X05/form4-12062025_011219.xmlSEC.gov

Graphics and non-inline formats (not embedded below).